Insights from a Cardiac Resynchronization Optimization Clinic As Part of a Heart Failure Disease Management Program
Overview
Authors
Affiliations
Objectives: Our aim was to determine the feasibility and value of a protocol-driven approach to patients with cardiac resynchronization therapy (CRT) who did not exhibit a positive response long after implant.
Background: Up to one-third of patients with advanced heart failure do not exhibit a positive response to CRT.
Methods: A total of 75 consecutive ambulatory patients with persistent advanced heart failure symptoms and/or adverse reverse remodeling and CRT implanted >6 months underwent a comprehensive protocol-driven evaluation to determine the potential reasons for a suboptimal response. Recommendations were made to maximize the potential of CRT, and adverse events were documented.
Results: All patients (mean left ventricular [LV] ejection fraction 23 +/- 9%, LV end-diastolic volume 275 +/- 127 ml) underwent evaluation. Eighty-eight percent of patients had significantly better echocardiographic indexes of LV filling and LV ejection with optimal setting of their CRT compared with a temporary VVI back-up setting. Most patients had identifiable reasons for suboptimal response, including inadequate device settings (47%), suboptimal medical treatment (32%), arrhythmias (32%), inappropriate lead position (21%), or lack of baseline dyssynchrony (9%). Multidisciplinary recommendations led to changes in device settings and/or other therapy modifications in 74% of patients and were associated with fewer adverse events (13% vs. 50%, odds ratio: 0.2 [95% confidence interval: 0.07 to 0.56], p = 0.002) compared with those in which no recommendation could be made.
Conclusions: Routine protocol-driven approach to evaluate ambulatory CRT patients who did not exhibit a positive response is feasible, and changes in device settings and/or other therapies after multidisciplinary evaluation may be associated with fewer adverse events.
Thibault B, Waddingham P, Badie N, Mangual J, McSpadden L, Betts T CJC Open. 2025; 7(2):166-175.
PMID: 40060211 PMC: 11886368. DOI: 10.1016/j.cjco.2024.11.003.
Tachibana M, Hayashida A, Take Y, Banba K, Kimura A, Shigematsu T Cureus. 2025; 17(2):e78912.
PMID: 39958404 PMC: 11825223. DOI: 10.7759/cureus.78912.
Taniguchi M, Oka T, Nakano T, Ozu K, Sekihara T, Sakata Y HeartRhythm Case Rep. 2025; 10(12):890-895.
PMID: 39897680 PMC: 11781880. DOI: 10.1016/j.hrcr.2024.08.023.
Optimizing outcomes from cardiac resynchronization therapy: what do recent data and insights say?.
de Vere F, Wijesuriya N, Howell S, Elliott M, Mehta V, Mannakkara N Expert Rev Cardiovasc Ther. 2024; 1-18.
PMID: 39695920 PMC: 11716670. DOI: 10.1080/14779072.2024.2445246.
Conduction system pacing in heart failure: Time for a paradigm shift?.
Vlachakis P, Theofilis P, Apostolos A, Kordalis A, Sideris S, Leventopoulos G Heart Fail Rev. 2024; 30(2):365-380.
PMID: 39579301 DOI: 10.1007/s10741-024-10469-9.